Sensible Biotechnologies logo

Sensible Biotechnologies

Unlocking the next generation of mRNA medicines

Oxford, GB

Synthetic BiologyBiotechManufacturingTherapeuticsBiotechnology
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
Meet the team2

The people behind Sensible Biotechnologies

Miroslav Gasparek
Miroslav Gasparek
Founder
LinkedIn profile
Marian Kupculak
Marian Kupculak
Founder
LinkedIn profile